Atorvastatin Reduces Expression of the CCR2 and MAC-1 Receptors on Monocytes, and Plasma Levels of Monocyte Chemoattractant Protein-1 and C-Reactive Protein, in Patients with Coronary Heart Disease

By Fernández-Cruz A.  

Clinical Drug Investigation, Vol. 22, Iss. 1, 2002-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Effect of NCB-02, Atorvastatin and Placebo on Endothelial Function, Oxidative Stress and Inflammatory Markers in Patients with Type 2 Diabetes Mellitus: A Randomized, Parallel-Group, Placebo-Controlled, 8-Week Study

By Usharani P.  

Drugs in R&D, Vol. 9, Iss. 4, 2008-01 ,pp. : 243-250

Adis International

Access to resources Recommend Favorite

Correlation Between Inflammation and Oxidative Stress in Normocholesterolemic Coronary Artery Disease Patients ‘on’ and ‘off’ Atorvastatin for Short Time Intervals

By Thomas M.   Narang D.   Lakshmy R.   Gupta R.   Naik N.   Maulik S.  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 1, 2006-02 ,pp. : 37-44

Springer Publishing Company

Access to resources Recommend Favorite

Reduced serum paraoxonase-1 levels in vitiligo: further evidence of oxidative stress

By Yesilova Yavuz   Turan Enver   Ucmak Derya   Selek Sahabettin   Halil Yavuz I˙brahim   Tanrıkulu Osman  

Redox Report, Vol. 17, Iss. 5, 2012-09 ,pp. : 214-218

Maney Publishing

Access to resources Recommend Favorite

Potential Use of Modulators of Oxidative Stress as Add-on Therapy in Patients with Anxiety Disorders

By  

Current Drug Targets, Vol. 19, Iss. 6, 2018-04 ,pp. : 636-650

Bentham Science Publishers

Access to resources Recommend Favorite